Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Psychoneuroendocrinology

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.psyneuen.2017.05.004PMID 28624654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus

  2018cited by this paper
• Experimentally induced diabetes worsens neuropathology, but not learning and memory, in middle aged 3xTg mice

  2017cited by this paper
• Regional functional synchronizations in dementia with Lewy bodies and Alzheimer's disease

  2016cited by this paper
• Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex

  2016cited by this paper
• Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.

  2016cited by this paper
• Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.

  2016cited by this paper
• Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology

  2016cited by this paper
• Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia

  2016cited by this paper
• Antidiabetic drugs restore abnormal transport of amyloid-β across the blood-brain barrier and memory impairment in db/db mice.

  2016cited by this paper
• Liver glucose metabolism in humans

  2016cited by this paper
• A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway

  2016cited by this paper
• Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma

  2016cited by this paper
• Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women

  2016cited by this paper
• Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.

  2016cited by this paper
• Failed Alzheimer’s trial does not kill leading theory of disease

  2016cited by this paper
• Autocrine Signaling Underlies Fast Repetitive Plasma Membrane Translocation of Conventional and Novel Protein Kinase C Isoforms in β Cells*

  2016cited by this paper
• GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

  2015cited by this paper
• Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.

  2015cited by this paper
• The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors

  2015cited by this paper
• Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

  2015cited by this paper
• Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors

  2015cited by this paper
• Neuronal LRP1 Regulates Glucose Metabolism and Insulin Signaling in the Brain

  2015cited by this paper
• Aberrant insulin signaling in Alzheimer's disease: current knowledge

  2015cited by this paper
• Insulin resistance predicts brain amyloid deposition in late middle‐aged adults

  2015cited by this paper
• Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation

  2015cited by this paper
• Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

  2015cited by this paper
• CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain

  2015cited by this paper
• Diabetes Mellitus Accelerates Aβ Pathology in Brain Accompanied by Enhanced GAβ Generation in Nonhuman Primates

  2015cited by this paper
• A Protein Kinase C Phosphorylation Motif in GLUT1 Affects Glucose Transport and is Mutated in GLUT1 Deficiency Syndrome.

  2015cited by this paper
• The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease

  2015cited by this paper
• Potential roles of PINK1 for increased PGC-1α-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes.

  2014cited by this paper
• The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex

  2014cited by this paper
• Common Mechanisms of Alzheimer's Disease and Ischemic Stroke: The Role of Protein Kinase C in the Progression of Age-Related Neurodegeneration

  2014cited by this paper
• Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study

  2014cited by this paper
• Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.

  2014cited by this paper
• Type 2 diabetes mellitus and Alzheimer's disease.

  2014cited by this paper
• Insulin Action in Brain Regulates Systemic Metabolism and Brain Function

  2014cited by this paper
• The hexosamine biosynthetic pathway induces gene promoter activity of acetyl-CoA carboxylase beta.

  2014cited by this paper
• Epigenetic Mechanisms Linking Diabetes and Synaptic Impairments

  2014cited by this paper
• Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention

  2014cited by this paper
• Effects of Statins on Incident Dementia in Patients with Type 2 DM: A Population-Based Retrospective Cohort Study in Taiwan

  2014cited by this paper
• Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms.

  2013cited by this paper
• Risk factors for dementia with type 2 diabetes mellitus among elderly people in China.

  2013cited by this paper
• Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

  2013cited by this paper
• Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention

  2013cited by this paper
• AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans

  2013cited by this paper
• Hexosamine biosynthesis impairs insulin action via a cholesterolgenic response.

  2013cited by this paper
• Diabetic Neuropathy and Oxidative Stress: Therapeutic Perspectives

  2013cited by this paper
• Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology

  2013cited by this paper
• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

  2013cited by this paper
• Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone.

  2013cited by this paper
• Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.

  2013cited by this paper
• Beyond amyloid: the future of therapeutics for Alzheimer's disease.

  2012cited by this paper
• AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation.

  2012cited by this paper
• Is RAGE still a therapeutic target for Alzheimer's disease?

  2012cited by this paper
• Cholesterol‐enriched membrane rafts and insulin secretion

  2012cited by this paper
• Structure and Pathology of Tau Protein in Alzheimer Disease

  2012cited by this paper
• Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• The role of mTOR signaling in Alzheimer disease.

  2012cited by this paper
• Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.

  2012cited by this paper
• Phosphorylation of Amyloid-β Peptide at Serine 8 Attenuates Its Clearance via Insulin-degrading and Angiotensin-converting Enzymes*

  2012cited by this paper
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

  2012cited by this paper
• Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial

  2011cited by this paper
• BRI2 Protein Regulates β-Amyloid Degradation by Increasing Levels of Secreted Insulin-degrading Enzyme (IDE)*♦

  2011cited by this paper
• Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation.

  2011cited by this paper
• Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

  2011cited by this paper
• Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice

  2011cited by this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011cited by this paper
• Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis

  2011cited by this paper
• Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin

  2011cited by this paper
• World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease

  2011cited by this paper
• Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.

  2011cited by this paper
• Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.

  2011cited by this paper
• Anti‐diabetic effects of resveratrol

  2011cited by this paper
• Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain

  2010cited by this paper
• AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism*

  2010cited by this paper
• Diabetes and insulin in regulation of brain cholesterol metabolism.

  2010cited by this paper
• Peroxisome proliferator-activated receptor gamma enhances the activity of an insulin degrading enzyme-like metalloprotease for amyloid-beta clearance.

  2010cited by this paper
• The role of GLP-1 in neuronal activity and neurodegeneration.

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

  2010cited by this paper
• Diabetes, Alzheimer disease, and vascular dementia

  2010cited by this paper
• Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress

  2010cited by this paper
• Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.

  2010cited by this paper
• Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease.

  2010cited by this paper
• Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease.

  2010cited by this paper
• Glut1 deficiency: Inheritance pattern determined by haploinsufficiency

  2010cited by this paper
• Downregulation of LRP1 [correction of LPR1] at the blood-brain barrier in streptozotocin-induced diabetic mice.

  2009cited by this paper
• Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

  2009cited by this paper
• Inflammation and NF-κB in Alzheimer's Disease and Diabetes

  2009cited by this paper
• Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

  2009cited by this paper
• Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease.

  2009cited by this paper
• Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription

  2009cited by this paper
• Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.

  2009cited by this paper
• Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin

  2008cited by this paper
• Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

  2008cited by this paper
• Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease

  2008cited by this paper
• Altered lipid metabolism in brain injury and disorders.

  2008cited by this paper

• Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance

  2026cites this paper
• Carboline Hybrids as Potential Multitarget‐Directed Anti‐Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure–Activity Relationships

  2025cites this paper
• Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets.

  2025cites this paper
• Sleep fragmentation impairs cognitive function and exacerbates Alzheimer's disease-related pathology in a mouse model by disrupting mitochondrial biogenesis.

  2025cites this paper
• Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis

  2025cites this paper
• Association between Cardiometabolic Index and Cognitive Function: A Cross-Sectional Study in a Diabetic-Based Population

  2024cites this paper
• Exploring complexities of Alzheimer's disease: New insights into molecular and cellular mechanisms of neurodegeneration and targeted therapeutic interventions.

  2024cites this paper
• Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

  2024cites this paper
• A Systematic Review of Preclinical Studies Exploring the Role of Insulin Signalling in Executive Function and Memory.

  2023cites this paper
• Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases

  2023cites this paper
• Simulated weightlessness induces hippocampal insulin resistance and cognitive impairment.

  2023cites this paper
• Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease.

  2022cites this paper
• Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease

  2022cites this paper
• The potential biological effects of quercetin based on pharmacokinetics and multi-targeted mechanism in vivo

  2022cites this paper
• Treadmill training attenuate STZ-induced congnitive dysfunction in Type 2 Diatetic Rats via modulating Grb10/ IGF-R signaling.

  2022cites this paper
• Downregulation of PIK3CB Involved in Alzheimer's Disease via Apoptosis, Axon Guidance, and FoxO Signaling Pathway

  2022cites this paper
• The role of type 2 Diabetes mellitus as a risk factor for Alzheimer's and Parkinson's diseases

  2021cites this paper
• Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms

  2021cites this paper
• Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model

  2021cites this paper
• Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes

  2021cites this paper
• Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease

  2021cites this paper
• Comprehensive Review on Neuro-Degenerative Type 3DM.

  2021cites this paper
• Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease

  2021cites this paper
• Impact of Gut Microbiome Manipulation in 5xFAD Mice on Alzheimer’s Disease-Like Pathology

  2021cites this paper
• Roles of glia-derived extracellular vesicles in central nervous system diseases: an update

  2021cites this paper
• Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer’s disease

  2021cites this paper
• Nanomedicines and phytochemicals targeting Alzheimer’s disease

  2021cites this paper
• Neurophysiological Study of Alzheimer’s Disease and Diabetes Mellitus Type 2 Patients. Is there a Common Link?

  2021cites this paper
• The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease

  2020cites this paper
• Low-dose intranasal insulin improves cognitive function and suppresses the development of epilepsy.

  2020cites this paper
• The dark side of Alzheimer’s disease: unstructured biology of proteins from the amyloid cascade signaling pathway

  2020cites this paper
• NDT_A_229206 55..70

  2020cites this paper
• Healthy Eating, Physical Activity, and Sleep Hygiene (HEPAS) as the Winning Triad for Sustaining Physical and Mental Health in Patients at Risk for or with Neuropsychiatric Disorders: Considerations for Clinical Practice

  2020cites this paper
• Insulin mediated novel therapies for the treatment of Alzheimer's disease.

  2020cites this paper
• Can dipeptidyl peptidase-4 inhibitors treat cognitive disorders?

  2020cites this paper
• Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages

  2020cites this paper
• Potential Biochemical Mechanisms of Brain Injury in Diabetes Mellitus

  2020cites this paper
• A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

  2020cites this paper
• Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease.

  2020cites this paper
• Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease.

  2020cites this paper
• Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of Parkin-mediated Mitophagy in in-vitro and in-vivo models of Parkinson disease.

  2020cites this paper
• Microbiota modulation as preventative and therapeutic approach in Alzheimer’s disease

  2020cites this paper
• The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy

  2020cites this paper
• Role of Insulin Signaling in the Pathophysiology of Alzheimer’s Disease

  2020cites this paper
• Healthy Eating, Physical Activity, and Sleep Hygiene (HEPAS) as the Winning Triad for Sustaining Physical and Mental Health in Patients at Risk for or with Neuropsychiatric Disorders: Considerations for Clinical Practice

  2020cites this paper
• Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANet

  2019cites this paper
• The influence of Zingiber officinale Roscoe on the histological changes of soft palatal mucosa in streptozotocin-induced type 3 diabetes rat model

  2019influential citation
• Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer's disease.

  2019cites this paper
• Cold-induced lipid dynamics and transcriptional programs in white adipose tissue

  2019cites this paper
• Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes

  2019cites this paper
• Outcomes and clinical implications of intranasal insulin administration to the central nervous system.

  2019cites this paper
• Role of Hypothalamic-Pituitary-Adrenal Axis, Hypothalamic-Pituitary-Gonadal Axis and Insulin Signaling in the Pathophysiology of Alzheimer’s Disease

  2019cites this paper
• Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer’s Disease

  2019cites this paper
• A Perspective to the Correlation Between Brain Insulin Resistance and Alzheimer: Medicinal Chemistry Approach.

  2019cites this paper
• The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia

  2018cites this paper
• The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus

  2018cites this paper
• Microglia‐derived extracellular vesicles in Alzheimer's Disease: A double‐edged sword

  2018cites this paper
• Curcumin, Cardiometabolic Health and Dementia

  2018cites this paper
• Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.

  2018cites this paper
• The Use of Anti-Diabetic Drugs in Alzheimer’s Disease, New Therapeutic Options and Future Perspective

  2018cites this paper
• Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues

  2018cites this paper
• Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects

  2018cites this paper
• Reversal of Alzheimer ’ s Disease and Optimization of Brain Health with Orthomolecular Medicine

  year unknowncites this paper